Industry Brief
What the Revised European Union’s Annex 11 Means to Life Science Companies
Loading Content
About this Document
What does this mean to life science companies and related suppliers currently in the EU market? First, Annex 11 is not a legal requirement but a guidance that applies to companies that manufacture or sell human and veterinary medicinal products in the 27 states belonging to the European Union.
PDF
— 0.23MB
